We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Stock Type |
---|---|---|---|
Polarean Imaging Plc | POLX | London | Ordinary Share |
Open Price | Low Price | High Price | Close Price | Previous Close |
---|---|---|---|---|
1.325 | 1.25 | 1.325 | 1.22 | 1.225 |
Industry Sector |
---|
PHARMACEUTICALS & BIOTECHNOLOGY |
Top Posts |
---|
Posted at 17/1/2025 08:32 by moontheloon 1 more full week struck off the calendar and cash runway before another fund raise. Meanwhile grinning vj is sunning it a week in san fran. Oh the life, meanwhile the uk shareholder of polx are destitute, and depressed. Should have followed me out at 1.7. Following earlier being out at 2.1 following the placing. Now the share price approaches offer price of 1p with nothing to stop it and resistance level downwards recently broken. |
Posted at 30/12/2024 07:57 by moontheloon There's not much pie to slice here.Time is of the essence and sub 10m dollars now. Another few months, and the clamour for the next survival funding and another massive dilution will build. Not healthy for the sp, re will polx survive, and if they get it off the ground again another jolt to the share price dilution wise. Plain to see to anyone that this is desperately too slow. Shame as the tech is valuable. But be probably picked up on the cheap in a fire sale from the ip holder. |
Posted at 25/11/2024 09:30 by m_night10 The 200DMA will soon be at low 2p level by the end of this week.Once it's there the technical lot are going to pile in as the price sits above the 50DMA and 100DMA. Then once it clears the 200DMA it goes to fill the gap to 3.4p They are already showing up to get their large amount of followers in. Recent interviews, news and articles has put this on radards. What will get it there? The following facts and news which is starting to come in. Mcap is tiny and cash position is huge to Q2 2026 and revenues are soaring.. I see it as a steal for the FDA approved Xenon MRI. No company debt, masssive growth potential in the worlds biggest health market the United States where it's already in 21 clinical settings, best in class next generation MRI. Revenues rising up 3000% to $3mil for 2024 and doubling again next to $6mil. 1.6p and gap at over 3p. ATH 100p. Cash runway to minimum of Q2 2026, looks set to be extended given revenues ahead of expectations. Putting this UK recovery play potential on radars. 1. September 18th 2024: Interventional radiology vendor Merit Medical to acquire device portfolio for $210M. APPROX 13P SHARE PRICE EQUIVALENT FOR POLX 2. September 25th 2024: Private equity firm acquiring diagnostic imaging provider for $658M APPROX 48P SHARE PRICE EQUIVALENT FOR POLX 3. October 14th 2024: Hologic to Acquire Gynesonics The women’s health company will be purchased for approximately $350 million. APPROX 22P SHARE PRICE EQUIVALENT FOR POLX 4. Bracco current major TR1 Holder of Polarean splashed out $450MILLION for a diagnostic buyout POLX easy buyout target more massive premiums as per the above imv. DYOR, no |
Posted at 21/11/2024 11:26 by m_night10 The 200DMA is going to be down to the low 2p level in about a week.Once it's there the technical lot are going to pile in as the price sits above the 50DMA and 100DMA. Then once it clears the 200DMA it goes to fill the gap to 3.4p They are already showing up to get their large amount of followers in. Case in point: 1. Stocksaimtrader/stat 2. Darrenukdaytra1/stat 3. ZaksTradersCafe/stat What will get it there? The following facts and news which is starting to come in. Mcap is tiny and cash position is huge to Q2 2026 and revenues are soaring.. I see it as a steal for the FDA approved Xenon MRI. No company debt, masssive growth potential in the worlds biggest health market the United States where it's already in 21 clinical settings, best in class next generation MRI. Revenues rising up 3000% to $3mil for 2024 and doubling again next to $6mil. 1.6p and gap at over 3p. ATH 100p. Cash runway to minimum of Q2 2026, looks set to be extended given revenues ahead of expectations. Putting this UK recovery play potential on radars. 1. September 18th 2024: Interventional radiology vendor Merit Medical to acquire device portfolio for $210M. APPROX 13P SHARE PRICE EQUIVALENT FOR POLX 2. September 25th 2024: Private equity firm acquiring diagnostic imaging provider for $658M APPROX 48P SHARE PRICE EQUIVALENT FOR POLX 3. October 14th 2024: Hologic to Acquire Gynesonics The women’s health company will be purchased for approximately $350 million. APPROX 22P SHARE PRICE EQUIVALENT FOR POLX 4. Bracco current major TR1 Holder of Polarean splashed out $450MILLION for a diagnostic buyout POLX easy buyout target more massive premiums as per the above imv. DYOR, no |
Posted at 15/11/2024 10:20 by m_night10 You waste your time and life moon. A few buys like the 740k you see now and it will go to 2p and then over with news faster than you can blink. :)POLX Polarean Imaging about to break out well above 2p soon. Mcap only $20mil. I see it as a steal for the FDA approved Xenon MRI. No company debt, masssive growth potential in the worlds biggest health market the United States where it's already in 21 clinical settings, best in class next generation MRI. Revenues rising up 3000% to $3mil for 2024 and doubling again next to $6mil. 1.6p and gap at to 3.4p. ATH 100p. Cash runway to minimum of Q1 2026, looks set to be extended given revenues ahead of expectations. Putting this UK recovery play potential on radars. 1. September 18th 2024: Interventional radiology vendor Merit Medical to acquire device portfolio for $210M. APPROX 13P SHARE PRICE EQUIVALENT FOR POLX 2. September 25th 2024: Private equity firm acquiring diagnostic imaging provider for $658M APPROX 48P SHARE PRICE EQUIVALENT FOR POLX 3. October 14th 2024: Hologic to Acquire Gynesonics The women’s health company will be purchased for approximately $350 million. APPROX 22P SHARE PRICE EQUIVALENT FOR POLX 4. Bracco current major TR1 Holder of Polarean splashed out $450MILLION for a diagnostic buyout POLX easy buyout target imv. DYOR, not advice. |
Posted at 14/11/2024 09:11 by m_night10 POLX Polarean Imaging about to break out well above 2p soon. Mcap only $20mil. I see it as a steal for the FDA approved Xenon MRI. No company debt, masssive growth potential in the worlds biggest health market the United States where it's already in 21 clinical settings, best in class next generation MRI. Revenues rising up 3000% to $3mil for 2024 and doubling again next to $6mil. 1.6p and gap at to 3.4p. ATH 100p. Cash runway to minimum of Q1 2026, looks set to be extended given revenues ahead of expectations.Putting this UK recovery play potential on radars. 1. September 18th 2024: Interventional radiology vendor Merit Medical to acquire device portfolio for $210M. APPROX 13P SHARE PRICE EQUIVALENT FOR POLX 2. September 25th 2024: Private equity firm acquiring diagnostic imaging provider for $658M APPROX 48P SHARE PRICE EQUIVALENT FOR POLX 3. October 14th 2024: Hologic to Acquire Gynesonics The women’s health company will be purchased for approximately $350 million. APPROX 22P SHARE PRICE EQUIVALENT FOR POLX 4. Bracco current major TR1 Holder of Polarean splashed out $450MILLION for a diagnostic buyout POLX easy buyout target imv. DYOR, not advice. |
Posted at 08/11/2024 08:36 by m_night10 POLX Polarean Imaging about to break out above 2p soon. Mcap only $25mil. I see it as a steal for the FDA approved Xenon MRI. No company debt, masssive growth potential in the worlds biggest health market the United States where it's already in 21 clinical settings, best in class next generation MRI. Revenues rising up 3000% to $3mil for 2024 and doubling again next to $6mil. 1.65p and gap at over 3p. ATH 100p. Cash runway to minimum of Q1 2026, looks set to be extended given revenues ahead of expectations.Putting this UK recovery play potential on radars. 1. September 18th 2024: Interventional radiology vendor Merit Medical to acquire device portfolio for $210M. APPROX 13P SHARE PRICE EQUIVALENT FOR POLX 2. September 25th 2024: Private equity firm acquiring diagnostic imaging provider for $658M APPROX 48P SHARE PRICE EQUIVALENT FOR POLX 3. October 14th 2024: Hologic to Acquire Gynesonics The women’s health company will be purchased for approximately $350 million. APPROX 22P SHARE PRICE EQUIVALENT FOR POLX 4. Bracco current major TR1 Holder of Polarean splashed out $450MILLION for a diagnostic buyout POLX easy buyout target imv. DYOR, not advice. |
Posted at 17/10/2024 15:19 by m_night10 POLX Mcap sub $20MIL right now I see it as a steal for Xenon MRI. No company debt, masssive growth potential, important best in class next generation MRI.1. September 18th 2024: Interventional radiology vendor Merit Medical to acquire device portfolio for $210M. APPROX 13P SHARE PRICE EQUIVALENT FOR POLX 2. September 25th 2024: Private equity firm acquiring diagnostic imaging provider for $658M APPROX 48P SHARE PRICE EQUIVALENT FOR POLX 3. October 14th 2024: Hologic to Acquire Gynesonics The women’s health company will be purchased for approximately $350 million. APPROX 22P SHARE PRICE EQUIVALENT FOR POLX 4. Bracco current major TR1 Holder of Polarean splashed out $450MILLION for a diagnostic buyout |
Posted at 26/9/2024 18:36 by m_night10 Also AGL fell from a £50m mcap now to like £25mcap. Watch it bounce back up again as always.POLX meanwhile is at a lowly £18mcap, barelt pricing in the cash and technology and revenues. Not only that the board are giving much more conservative guidance which so far it has delivered on, which is why when the interim results came a few weeks ago the price went UP. Unlike rampy Newland at Angle who consistent over promises and under delivers and thus a dump today. Not only that but POLX is set to have comparable revenues to ANGLE from a much lower market cap all whilst have more cash in the bank AND technology that is an easier sell to the clinical sites and they are coming in their droves. From 1.5p I fancy 5-6p EOY for POLX. |
Posted at 19/7/2024 10:09 by fft Errr. POLX are buying the older machines and selling them the newer ones. There is no mention of how much POLX are paying for them, and I suspect it is higher than the price POLX will get when they try and sell them again !This seems like a loss leader to get influential people involved. Note, there is no quote from the Virginia people saying how they always wanted the POLX kit. Indeed, unless I have looked at a wrong version of the RNS there is no quote at all In other words POLX are probably losing money on this deal and if other sites see this they may also like to do a trade in, but the more that do it the worse for POLX cash flow. My 2 cents |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions